4.8 Article

Genome remodelling in a basal-like breast cancer metastasis and xenograft

Journal

NATURE
Volume 464, Issue 7291, Pages 999-1005

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nature08989

Keywords

-

Funding

  1. Washington University in St Louis
  2. National Human Genome Research Institute (NHGRI) [U54 HG003079]
  3. National Cancer Institute (NCI) [1 U01 CA114722-01]
  4. Susan G Komen Breast Cancer Foundation [BCTR0707808]
  5. Fashion Footwear Charitable Foundation, Inc. [NCI U10 CA076001, NCI 3P50 CA68438]
  6. Breast Cancer Research Foundation
  7. Institute of Clinical and Translational Sciences at Washington University [UL1 RR024992]
  8. Illumina, Inc.

Ask authors/readers for more resources

Massively parallel DNA sequencing technologies provide an unprecedented ability to screen entire genomes for genetic changes associated with tumour progression. Here we describe the genomic analyses of four DNA samples from an African-American patient with basal-like breast cancer: peripheral blood, the primary tumour, a brain metastasis and a xenograft derived from the primary tumour. The metastasis contained two de novo mutations and a large deletion not present in the primary tumour, and was significantly enriched for 20 shared mutations. The xenograft retained all primary tumour mutations and displayed a mutation enrichment pattern that resembled the metastasis. Two overlapping large deletions, encompassing CTNNA1, were present in all three tumour samples. The differential mutation frequencies and structural variation patterns in metastasis and xenograft compared with the primary tumour indicate that secondary tumours may arise from a minority of cells within the primary tumour.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available